Effect of hypoandrogenism on expression of transient receptor potential vanilloid channels in rat penile corpus cavernosum and erectile function

J Sex Med. 2023 Aug 25;20(9):1153-1160. doi: 10.1093/jsxmed/qdad093.

Abstract

Background: Hypoandrogenism is a cause of erectile dysfunction (ED). Vascular smooth muscle cell contraction and relaxation are regulated by TRPV1-4 channels. However, the influence of hypoandrogenism on TRPV1-4 and its relationship with erectile function remain unclear.

Aim: To reveal whether hypoandrogenism affects erectile function by influencing TRPV1-4 expression in the corpus cavernosum of rats.

Methods: Male Sprague-Dawley rats (N = 36) aged 8 weeks were assigned to 6 groups at random (n = 6): sham operation, castrated, castrated + testosterone replacement, sham operation + transfection, castrated + transfection, and castrated + empty transfection. Four weeks after castration, 20 μL of lentiviral vector (1 × 108 TU/mL) carrying the TRPV4 gene was injected into the penile cavernous tissue of the transfection groups. One week after transfection, the maximum intracavernous pressure (ICPmax)/mean arterial pressure (MAP) and the content of TRPV1-4, phosphorylated eNOS (p-eNOS)/eNOS, and nitric oxide (NO) in penile cavernous tissue of each group were measured.

Outcomes: Under low androgen conditions, TRPV4 expression in endothelial cells in the rat penile cavernosum was sharply reduced, resulting in a decrease in p-eNOS/eNOS and NO content, which could inhibit erectile function.

Results: In rat penile cavernous tissue, TRPV1-4 was expressed in the cell membranes of endothelial cells and smooth muscle cells. The ICPmax/MAP and the content of TRPV4, p-eNOS/eNOS, and NO end product nitrite level in rat penile cavernous tissue was markedly reduced in the castrated group as compared with the sham group (P < .05). The ICPmax/MAP and the content of TRPV4, p-eNOS/eNOS, and NO end product nitrite level in rat penile cavernous tissue were markedly improved in the castrated + transfection group vs the castrated group (P < .01).

Clinical implications: Upregulation of TRPV4 expression in penile cavernosum tissue might be a viable therapeutic for ED caused by hypoandrogenism.

Strengths and limitations: The specific mechanism of TRPV4 in ED needs to be further verified by androgen receptor or TRPV4 gene knockout experiments.

Conclusion: Hypoandrogenism may cause ED by reducing the expression of TRPV4 in rat penile cavernous tissue. Upregulation of TRPV4 expression in penile cavernous tissue can increase the ratio of p-eNOS/eNOS and NO levels and ameliorate the erectile function of castrated rats.

Keywords: TRPV; eNOS; erectile dysfunction; hypoandrogenism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Endothelial Cells / metabolism
  • Erectile Dysfunction* / etiology
  • Humans
  • Male
  • Nitric Oxide Synthase Type III / metabolism
  • Nitrites / metabolism
  • Nitrites / pharmacology
  • Nitrites / therapeutic use
  • Penile Erection / physiology
  • Penis
  • Rats
  • Rats, Sprague-Dawley
  • TRPV Cation Channels / genetics
  • TRPV Cation Channels / metabolism
  • TRPV Cation Channels / pharmacology
  • Transient Receptor Potential Channels* / metabolism
  • Transient Receptor Potential Channels* / pharmacology
  • Transient Receptor Potential Channels* / therapeutic use

Substances

  • TRPV Cation Channels
  • Transient Receptor Potential Channels
  • Nitrites
  • Nitric Oxide Synthase Type III